Hua Lv Biotechnology Co Ltd

Legal Opinion on Jiangsu Hualv Biotechnology Group Co., Ltd. 2025 Annual Shareholders Meeting

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Announcement on the Completion of the Share Reduction Plan by Specific Shareholders

Announcement on Using Idle Self-Owned Funds for Cash Management

2025 Annual Board of Directors' Work Report

Company Announcement on Applying for Comprehensive Credit Limits from Financial Institutions for 2026

Announcement on the 2026 Compensation for Directors and Senior Management

Announcement on the Renewal of the 2026 Audit Institution

Independent Director's Work Report (Zhang Yingming)

Independent Director's Work Report (Liu Zhiyu)

Independent Director's Work Report (Yang Yan)

Announcement on Holding the 2025 Online Performance Briefing

2025 Annual Internal Control Audit Report

2025 Annual Internal Control Evaluation Report

Announcement on Increasing Business Scope, Changing Registered Capital, and Revising the Articles of Association and Handling Business Registration Changes

Company Articles of Association (April 2026)

Information Disclosure Suspension and Exemption Management System

Compensation Management System for Directors and Senior Management

Review Opinion of the First Meeting of the Fifth Board of Directors' Independent Directors' Special Meeting in 2026

Announcement on the Estimated Routine Related Transaction Limit for 2026

Announcement on the Estimated External Guarantee Limit for 2026

Notice of the 2025 Annual Shareholders' Meeting

Resolution Announcement of the 21st Meeting of the Fifth Board of Directors

Announcement on the 2025 Profit Distribution Plan

2026 First Quarter Report

Audit Committee of the Board of Directors' Report on the Evaluation of the Accounting Firm's Performance in 2025 and Fulfillment of Supervision Responsibilities

Special Explanation on the Company's 2025 Non-Operating Fund Occupation and Other Related Fund Transactions

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions

Board of Directors' Special Opinion on the Independence of Independent Directors in 2025

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary